CG
GBT

Cutler Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Cutler Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,900
Closed -$11K – 6007
2022
Q1 		$11K Buy
4,900
+1,500
+44% +$44.8K ﹤0.01% 3578
2021
Q4 		$10K Buy
3,400
+3,000
+750% +$92.9K ﹤0.01% 3749
2021
Q3 		$2K Sell
400
-500
-56% -$14.7K ﹤0.01% 5186
2021
Q2 		$1K Buy
900
+400
+80% +$15.6K ﹤0.01% 5524
2021
Q1 		$1K Sell
500
-11,200
-96% -$515K ﹤0.01% 5484
2020
Q4 		$25K Buy
11,700
+1,000
+9% +$49.3K ﹤0.01% 2525
2020
Q3 		$36K Buy
10,700
+10,000
+1,429% +$636K ﹤0.01% 2024
2020
Q2 		$3K Sell
700
-1,000
-59% -$68.6K ﹤0.01% 3697
2020
Q1 		$37K Buy
1,700
+800
+89% +$53.6K ﹤0.01% 1920
2019
Q4 		$1K Sell
900
-1,700
-65% -$101K ﹤0.01% 3841
2019
Q3 		$15K Sell
2,600
-13,400
-84% -$698K ﹤0.01% 2389
2019
Q2 		$76K Buy
16,000
+15,400
+2,567% +$885K 0.01% 1262
2019
Q1 		$4K Sell
600
-14,700
-96% -$722K ﹤0.01% 3110
2018
Q4 		$30K Buy
15,300
+800
+6% +$30K ﹤0.01% 1824
2018
Q3 		$118K Sell
14,500
-17,100
-54% -$757K 0.01% 1107
2018
Q2 		$179K Buy
31,600
+16,100
+104% +$733K 0.01% 829
2018
Q1 		$170K Sell
15,500
-21,000
-58% -$1.17M 0.01% 904
2017
Q4 		$66K Buy
36,500
+34,700
+1,928% +$1.3M ﹤0.01% 1668
2017
Q3 		$5K Sell
1,800
-20,200
-92% -$568K ﹤0.01% 4458
2017
Q2 		$66K Sell
22,000
-3,400
-13% -$101K ﹤0.01% 2216
2017
Q1 		$28K Buy
25,400
+16,100
+173% +$405K ﹤0.01% 2997
2016
Q4 		$21K Buy
9,300
+1,500
+19% +$26.4K ﹤0.01% 3447
2016
Q3 		$20K Buy
7,800
+3,100
+66% +$59.1K ﹤0.01% 3443
2016
Q2 		$15K Buy
4,700
+3,500
+292% +$70.6K ﹤0.01% 3698
2016
Q1 		$5K Buy
+1,200
New +$21.3K ﹤0.01% 4921

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's GBT Position: Q4 2022 in Review

Cutler Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 800 shares — an estimated $54K sold.

Cutler Group first reported a position in GBT in Q1 2016 and held it in 24 quarters. The position peaked at $1.05M in Q4 2017. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Cutler Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 800 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $54K.
  • Cutler Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 24 quarters.
  • Cutler Group's Global Blood Therapeutics, Inc. position peaked at $1.05M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.